Suppr超能文献

吡格列酮导致线粒体呼吸链复合物 I 的失活和解体。

Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chain.

机构信息

Research Center, Laboratory of Gastroenterology and Hepatology, University Hospital 12 de Octubre, Complutense University, Madrid 28041, Spain.

出版信息

BMC Biol. 2013 Aug 1;11:88. doi: 10.1186/1741-7007-11-88.

Abstract

BACKGROUND

Thiazolidinediones are antidiabetic agents that increase insulin sensitivity but reduce glucose oxidation, state 3 respiration, and activity of complex I of the mitochondrial respiratory chain (MRC). The mechanisms of the latter effects are unclear. The aim of this study was to determine the mechanisms by which pioglitazone (PGZ), a member of the thiazolidinedione class of antidiabetic agents, decreases the activity of the MRC. In isolated mitochondria from mouse liver, we measured the effects of PGZ treatment on MRC complex activities, fully-assembled complex I and its subunits, gene expression of complex I and III subunits, and [3H]PGZ binding to mitochondrial complexes.

RESULTS

In vitro, PGZ decreased activity of complexes I and III of the MRC, but in vivo only complex I activity was decreased in mice treated for 12 weeks with 10 mg/kg/day of PGZ. In vitro treatment of isolated liver mitochondria with PGZ disassembled complex I, resulting in the formation of several subcomplexes. In mice treated with PGZ, fully assembled complex I was increased and two additional subcomplexes were found. Formation of supercomplexes CI+CIII2+CIVn and CI+CIII2 decreased in mouse liver mitochondria exposed to PGZ, while formation of these supercomplexes was increased in mice treated with PGZ. Two-dimensional analysis of complex I using blue native/sodium dodecyl sulfate polyacrylamide gel electrophoresis (BN/SDS-PAGE) showed that in vitro PGZ induced the formation of four subcomplexes of 600 (B), 400 (C), 350 (D), and 250 (E) kDa, respectively. Subcomplexes B and C had NADH:dehydrogenase activity, while subcomplexes C and D contained subunits of complex I membrane arm. Autoradiography and coimmunoprecipitation assays showed [3H]PGZ binding to subunits NDUFA9, NDUFB6, and NDUFA6. Treatment with PGZ increased mitochondrial gene transcription in mice liver and HepG2 cells. In these cells, PGZ decreased intracellular ATP content and enhanced gene expression of specific protein 1 and peroxisome-proliferator activated receptor (PPAR)γ coactivator 1α (PGC-1α).

CONCLUSIONS

PGZ binds complex I subunits, which induces disassembly of this complex, reduces its activity, depletes cellular ATP, and, in mice and HepG2 cells, upregulates nuclear DNA-encoded gene expression of complex I and III subunits.

摘要

背景

噻唑烷二酮类是一种抗糖尿病药物,能增加胰岛素敏感性,但会降低葡萄糖氧化和线粒体呼吸链(MRC)的状态 3 呼吸及复合物 I 的活性。后者的作用机制尚不清楚。本研究旨在确定吡格列酮(PGZ)作为噻唑烷二酮类抗糖尿病药物降低 MRC 活性的机制。我们在来自小鼠肝脏的分离线粒体中测量了 PGZ 处理对 MRC 复合物活性、完全组装的复合物 I 及其亚基、复合物 I 和 III 亚基的基因表达以及[3H]PGZ 与线粒体复合物结合的影响。

结果

在体外,PGZ 降低了 MRC 的复合物 I 和 III 的活性,但在体内,仅在 10mg/kg/天 PGZ 治疗 12 周的小鼠中观察到复合物 I 活性降低。体外用 PGZ 处理分离的肝线粒体可使复合物 I 解体,形成几个亚基。在接受 PGZ 治疗的小鼠中,完全组装的复合物 I 增加,发现了另外两个亚基。暴露于 PGZ 的小鼠肝线粒体中超复合物 CI+CIII2+CIVn 和 CI+CIII2 的形成减少,而用 PGZ 治疗的小鼠中超复合物的形成增加。使用蓝色非变性/十二烷基硫酸钠聚丙烯酰胺凝胶电泳(BN/SDS-PAGE)对复合物 I 进行二维分析显示,在体外 PGZ 诱导形成分子量分别为 600(B)、400(C)、350(D)和 250(E)kDa 的四个亚基。亚基 B 和 C 具有 NADH:脱氢酶活性,而亚基 C 和 D 含有复合物 I 膜臂的亚基。放射自显影和共免疫沉淀检测显示[3H]PGZ 与亚基 NDUFA9、NDUFB6 和 NDUFA6 结合。PGZ 处理增加了小鼠肝脏和 HepG2 细胞的线粒体基因转录。在这些细胞中,PGZ 降低了细胞内 ATP 含量并增强了特异性蛋白 1 和过氧化物酶体增殖物激活受体(PPAR)γ共激活因子 1α(PGC-1α)的基因表达。

结论

PGZ 与复合物 I 的亚基结合,诱导该复合物解体,降低其活性,耗尽细胞内 ATP,并在小鼠和 HepG2 细胞中上调核 DNA 编码的复合物 I 和 III 亚基的基因表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1bf/3751493/120f5a343436/1741-7007-11-88-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验